Voyager Therapeutics, Inc. (VYGR)
Voyager Therapeutics, Inc. (VYGR) Insider Trading
Directors, officers and holders of more than 10% of VYGR report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 69 transactions on file: 0 with code P, 15 with code S and 35 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | MACKEY CATHERINE J | Director | A Award | 30,000 | Not measured | Not measured |
| Jun 9, 2026 | SCANGOS GEORGE A | Director | A Award | 30,000 | Not measured | Not measured |
| Jun 9, 2026 | Colon Grace | Director | A Award | 30,000 | Not measured | Not measured |
| Jun 9, 2026 | GERAGHTY JAMES A | Director | A Award | 30,000 | Not measured | Not measured |
| Jun 9, 2026 | Onyia Jude | Director | A Award | 30,000 | Not measured | Not measured |
| Jun 9, 2026 | Higgins Michael J | Director | A Award | 30,000 | Not measured | Not measured |
| Jun 9, 2026 | Vitale Nancy | Director | A Award | 30,000 | Not measured | Not measured |
| Jun 9, 2026 | PIERCE GLENN | Director | A Award | 30,000 | Not measured | Not measured |
| Jun 9, 2026 | Hyman Steven | Director | A Award | 30,000 | Not measured | Not measured |
| Apr 2, 2026 | Sandrock Alfred | President and CEO | S Sale | 11,511 | $3.87 | $44,548 |
| Apr 1, 2026 | Shiferman Gregory L. | SVP and General Counsel | A Award | 50,000 | Not measured | Not measured |
| Feb 24, 2026 | Swartz Robin | COO & CBO | S Sale | 6,458 | $3.77 | $24,347 |
| Feb 24, 2026 | Sandrock Alfred | President and CEO | S Sale | 14,197 | $3.79 | $53,807 |
| Feb 24, 2026 | Jorgensen Nathan D. | Chief Financial Officer | S Sale | 4,668 | $3.77 | $17,598 |
| Feb 24, 2026 | Carter Todd Alfred | Chief Scientific Officer | S Sale | 4,174 | $3.76 | $15,694 |
| Feb 18, 2026 | Swartz Robin | COO & CBO | S Sale | 3,882 | $3.44 | $13,354 |
| Feb 18, 2026 | Sandrock Alfred | President and CEO | S Sale | 11,732 | $3.41 | $40,006 |
| Feb 18, 2026 | Carter Todd Alfred | Chief Scientific Officer | S Sale | 3,301 | $3.44 | $11,355 |
| Feb 10, 2026 | Carter Todd Alfred | Chief Scientific Officer | S Sale | 3,525 | $3.85 | $13,571 |
| Feb 10, 2026 | Swartz Robin | COO & CBO | S Sale | 4,569 | $3.85 | $17,591 |
| Feb 10, 2026 | Sandrock Alfred | President and CEO | S Sale | 12,192 | $3.78 | $46,086 |
| Feb 6, 2026 | Jorgensen Nathan D. | Chief Financial Officer | A Award | 150,500 | Not measured | Not measured |
| Feb 6, 2026 | Ferguson Toby | Chief Medical Officer | A Award | 45,000 | Not measured | Not measured |
| Feb 6, 2026 | Carter Todd Alfred | Chief Scientific Officer | A Award | 33,000 | Not measured | Not measured |
| Feb 6, 2026 | Swartz Robin | COO & CBO | A Award | 45,000 | Not measured | Not measured |
| Feb 6, 2026 | Sandrock Alfred | President and CEO | A Award | 86,250 | Not measured | Not measured |
| Feb 6, 2026 | Jorgensen Nathan D. | Chief Financial Officer | A Award | 32,250 | Not measured | Not measured |
| Feb 6, 2026 | Ferguson Toby | Chief Medical Officer | A Award | 210,000 | Not measured | Not measured |
| Feb 6, 2026 | Carter Todd Alfred | Chief Scientific Officer | A Award | 154,000 | Not measured | Not measured |
| Feb 6, 2026 | Swartz Robin | COO & CBO | A Award | 210,000 | Not measured | Not measured |
| Feb 6, 2026 | Sandrock Alfred | President and CEO | A Award | 402,500 | Not measured | Not measured |
| Jan 6, 2026 | Shiferman Gregory L. | SVP and General Counsel | A Award | 100,000 | Not measured | Not measured |
| Oct 3, 2025 | Jorgensen Nathan D. | Chief Financial Officer | S Sale | 7,666 | $4.78 | $36,643 |
| Aug 18, 2025 | Ferguson Toby | Chief Medical Officer | S Sale | 19,000 | $3.73 | $70,870 |
| Jun 3, 2025 | Colon Grace | Director | A Award | 24,000 | Not measured | Not measured |
| Jun 3, 2025 | GERAGHTY JAMES A | Director | A Award | 24,000 | Not measured | Not measured |
| Jun 3, 2025 | Vitale Nancy | Director | A Award | 24,000 | Not measured | Not measured |
| Jun 3, 2025 | MACKEY CATHERINE J | Director | A Award | 24,000 | Not measured | Not measured |
| Jun 3, 2025 | Higgins Michael J | Director | A Award | 24,000 | Not measured | Not measured |
| Jun 3, 2025 | Hyman Steven | Director | A Award | 24,000 | Not measured | Not measured |
| Jun 3, 2025 | SCANGOS GEORGE A | Director | A Award | 24,000 | Not measured | Not measured |
| Jun 3, 2025 | Onyia Jude | Director | A Award | 24,000 | Not measured | Not measured |
| Jun 3, 2025 | PIERCE GLENN | Director | A Award | 24,000 | Not measured | Not measured |
| Apr 2, 2025 | Sandrock Alfred | President and CEO | S Sale | 10,885 | $3.43 | $37,336 |
| Apr 2, 2025 | Ferguson Toby | Chief Medical Officer | S Sale | 10,086 | $3.43 | $34,595 |
| Feb 21, 2025 | Carter Todd Alfred | Chief Scientific Officer | A Award | 46,000 | Not measured | Not measured |
| Feb 21, 2025 | Carter Todd Alfred | Chief Scientific Officer | A Award | 92,000 | Not measured | Not measured |
| Feb 21, 2025 | Sandrock Alfred | President and CEO | A Award | 290,000 | Not measured | Not measured |
| Feb 21, 2025 | Ferguson Toby | Chief Medical Officer | A Award | 126,000 | Not measured | Not measured |
| Feb 21, 2025 | Jorgensen Nathan D. | Chief Financial Officer | A Award | 103,000 | Not measured | Not measured |
The full Form 4 history is on the VYGR company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.